Work

Huntingtin-Lowering Therapies for Huntington Disease

Year: 2020

Type: review

Source: JAMA Neurology

DOI: 10.1001/jamaneurol.2020.0299

Authors: Blair R. Leavitt, Holly B. Kordasiewicz, Scott A. Schobel

Institutions: University of British Columbia, BC Children's Hospital, Ionis Pharmaceuticals (United States), F. Hoffmann-La Roche AG

Language: English

Topic: Genetic Neurodegenerative Diseases

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3012750149

FWCI: 1.211

Cites: 48

Cited by: 72

Related to: 10